NDASA respects and is committed to protecting your privacy. We may collect personally identifiable information when you visit our site. We also automatically receive and record information on our server logs from your browser, including your IP address, cookie information and the page(s) you visited. We will not sell your personally identifiable information to anyone if you have indicated you do not wish for your information to be shared with others within your profile settings.
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Apr 26, 2024Be The Voice: NDASA members, we want to feature you in the next issue of our industry e-magazine
- Apr 24, 2024Turning strangers into customers: Leverage incoming calls to boost your sales
- Apr 12, 2024The value of townhalls
- Apr 12, 2024May is Mental Health Awareness Month
- Apr 12, 2024Drugs you need to be testing for this quarter – Recommended scope for novel psychoactive substance (NPS) testing in the U.S.
Topics We Track
- Advocacy (5)
- Business Development (5)
- Committee Reports (1)
- DOT (11)
- Drug & Alcohol Testing (42)
- Drug Legislation (10)
- Feature (90)
- FMCSA (7)
- For Drug Testing Industry Professionals (15)
- For Employers and Workplace Safety & Wellness Professionals (15)
- Industry News (26)
- Marijuana & CBD (16)
- Member Benefits (3)
- Membership (6)
- NDASA Conference (13)
- NDASA Guidance (4)
- NDASA News (3)
- Newsletter Only (5)
- Opioids (2)
- Resources (24)
- Substance Use (3)
- Substance Use/Addiction (8)
- Training (3)
- Uncategorized (12)
- Workplace Safety (10)
- Be The Voice: NDASA members, we want to feature you in the next issue of our industry e-magazine
- Turning strangers into customers: Leverage incoming calls to boost your sales
- The value of townhalls
- May is Mental Health Awareness Month
- Drugs you need to be testing for this quarter – Recommended scope for novel psychoactive substance (NPS) testing in the U.S.